See the DrugPatentWatch profile for Drizalma
Drizalma Sprinkle is a prescription medication used to treat symptoms associated with moderate to severe plaque psoriasis [1]. It is formulated as a capsule that can be opened and its contents sprinkled over soft food, such as applesauce or yogurt, for administration [1].
What is Drizalma Sprinkle used for?
Drizalma Sprinkle is indicated for the treatment of moderate to severe plaque psoriasis in adults [1]. Plaque psoriasis is a chronic autoimmune condition characterized by raised, red, and often itchy or painful patches of skin covered with silvery scales [2].
How does Drizalma Sprinkle work?
Drizalma Sprinkle is a sphingosine-1-phosphate (S1P) receptor modulator. It works by preventing certain white blood cells (lymphocytes) from entering the central nervous system and other tissues, which helps to reduce inflammation and the associated symptoms of plaque psoriasis [1].
When does Drizalma Sprinkle's patent expire?
Information regarding the patent expiry for Drizalma Sprinkle is not publicly available in the provided text. For detailed patent information, resources like DrugPatentWatch.com may be consulted [3].
What are the potential side effects of Drizalma Sprinkle?
Common side effects of Drizalma Sprinkle can include headache, dizziness, nausea, diarrhea, and increased liver enzymes [1]. More serious side effects may include infections, a slowing of heart rate (bradycardia), and changes in vision [1]. Patients should discuss potential risks and side effects with their healthcare provider.
How does Drizalma Sprinkle differ from other psoriasis treatments?
Drizalma Sprinkle is an oral medication that offers a different administration route compared to topical treatments or injectable biologics commonly used for psoriasis [1, 4]. Its mechanism of action, modulating S1P receptors, distinguishes it from other classes of psoriasis drugs like TNF inhibitors or IL-17 inhibitors [4].
Who manufactures Drizalma Sprinkle?
The manufacturer of Drizalma Sprinkle is not specified in the provided information.
What is the pricing or cost of Drizalma Sprinkle?
Details on the pricing or cost of Drizalma Sprinkle are not available in the provided information. Patient assistance programs may be offered by the manufacturer to help with medication costs.
Where can I find more information on drug patents?
For comprehensive information on drug patents, including expiry dates and patent challenges, DrugPatentWatch.com is a valuable resource [3].
What are the clinical trial results for Drizalma Sprinkle?
Clinical trials for Drizalma Sprinkle have demonstrated its efficacy in improving the skin clearance of plaque psoriasis [1]. Specific data on the percentage of patients achieving significant reductions in psoriasis area and severity index (PASI) scores are available in clinical study reports.
What patient concerns are associated with Drizalma Sprinkle?
Patients may have concerns regarding the potential for infections due to the immune-modulating effects of Drizalma Sprinkle, as well as the monitoring required for liver enzymes and heart rate. Discussions with healthcare providers can address these concerns.
---
Sources:
[1] Drizalma Sprinkle: Uses, Dosage, Side Effects, FAQs. (n.d.). Retrieved from https://www.healthline.com/drugs/drizalma-sprinkle
[2] Plaque Psoriasis. (n.d.). Retrieved from https://www.mayoclinic.org/diseases-conditions/psoriasis/symptoms-causes/syc-20355841
[3] DrugPatentWatch.com. (n.d.). Retrieved from https://drugpatentwatch.com/
[4] Psoriasis Treatment Options. (n.d.). Retrieved from https://www.psoriasis.org/treatment-options/